glp-1 receptor agonists effectiveness comparison GLP1 vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 Medications for Weight Loss:
Description
The mechanism of action of GLP-1 agonists involves binding to GLP-1 receptors on pancreatic beta cells, which stimulates glucose-dependent insulin secretion
Above all, Epigenetic dysregulation in PCOSincluding DNA methylation, histone modifications, and non-coding RNA alterationsdisrupts ovarian function, hormone balance, and insulin signaling, contributing to hyperandrogenism, metabolic dysfunction, and impaired folliculogenesis
Importantly, no limiting side effects were recorded (48), providing proof of concept in 2002 for GLP-1 therapy in subjects with T2D
31 , 11891205.e1113 (2020)
PMC 304885
